Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Senators Seek Details on Gilead's Solvaldi Pricing

July 14, 2014 1:53 pm | News | Comments

Senate Finance Committee Chairman Ron Wyden, D-Ore., and senior Finance Committee member Chuck Grassley, R-Iowa, are requestinh detailed pricing information on the costly new Hepatitis C virus (HCV) drug Solvaldi. Read more...        

TOPICS:

New Technology Delivers Cargo, Doesn’t Disrupt Cell

July 14, 2014 10:59 am | News | Comments

Portage Biotech announced that Portage Pharmaceuticals has successfully validated a new proprietary cell permeable peptide platform technology derived from human genes that delivers an active pharmacological agent or cargo into a cell without disrupting the cell membrane. Read more...

TOPICS:

Mylan to Buy Abbott Generic-Drugs Business for $5.3B

July 14, 2014 10:50 am | News | Comments

The generic drugmaker Mylan is buying Abbott Laboratories' generic-drugs business in developed markets for stock valued at about $5.3 billion in a deal that will diversify and expand its business outside the U.S. when the combined company is organized in the Netherlands. Read more...

TOPICS:
Advertisement

Oral Drug Improves Vision in Patients with Inherited Blindness

July 14, 2014 10:43 am | News | Comments

An international research project, led by the Research Institute of the McGill University Health Centre in Montreal, reported that a new oral medication is showing significant progress in restoring vision to patients with Leber congenital amaurosis (LCA). Read more...

TOPICS:

Melanoma Drug Combo Meets Primary Endpoint

July 14, 2014 10:34 am | News | Comments

Roche announced that the Phase 3 coBRIM study met its primary endpoint when it demonstrated that cobimetinib, used in combination with Zelboraf, helped patients with previously untreated BRAF V600 mutation-positive advanced melanoma live significantly longer without their disease worsening compared to Zelboraf alone. Read more...

TOPICS:

China Indicts U.S., British Investigators

July 14, 2014 10:28 am | by Gillian Wong, Associated Press | News | Comments

Chinese authorities have indicted British and American investigators hired by GlaxoSmithKline on charges of illegally obtaining and selling private information, state media reported Monday, as the Briton blamed the pharmaceutical company for misleading and using him. Read more...

TOPICS:

Ebola Crisis Deepens, 500+ Dead

July 14, 2014 10:22 am | by Krista Larson, Associated Press | News | Comments

Deep in the forests of southern Guinea, the first victims fell ill with high fevers. People assumed it was the perennial killer malaria and had no reason to fear touching the bodies, as is the custom in traditional funerals, and unknowingly spread what ultimately was discovered to be Ebola. Read more...

TOPICS:

AbbVie, Shire Enter Detailed Combination Talks

July 14, 2014 7:23 am | by Tom Murphy, AP Business Writer | News | Comments

Drugmakers AbbVie and Shire have entered detailed talks about a possible combination after AbbVie raised its bid once again and offered to give Shire shareholders a bigger stake in the resulting company. Read more...          

TOPICS:
Advertisement

Significant Increase in Antibiotic Use Across the World, Study Shows

July 11, 2014 3:23 pm | News | Comments

Global use of antibiotics is surging, according to researchers who have conducted a broad assessment of antibiotic consumption around the world. Read more...                            

TOPICS:

Ipsen, Galderma Expand Neurotoxin Partnership

July 11, 2014 3:16 pm | News | Comments

Ipsen, a global specialty-driven pharmaceutical company, and Galderma, a global healthcare company focused on dermatology and skin health, announced that they have significantly expanded the scope of their neurotoxin partnership. Read more...   

TOPICS:

New Compound Treats Blindness, Diabetes in Mice

July 11, 2014 3:03 pm | News | Comments

In a new study, a chemical compound designed to precisely target part of a crucial cellular quality-control network provided significant protection, in rats and mice, against degenerative forms of blindness and diabetes. Read more...      

TOPICS:

Girl Hoped to Have Been Cured of HIV Has Relapsed

July 11, 2014 2:51 pm | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

A Mississippi girl born with the AIDS virus and in remission for more than two years despite stopping treatment now shows signs that she still harbors HIV- and therefore is not cured. Read more...                

TOPICS:

Sanofi Dengue Shot Offers Some Protection

July 11, 2014 2:45 pm | by Maria Cheng, AP Medical Writer | News | Comments

The most advanced vaccine for dengue only offers modest protection but could still help millions of people avoid the devastating effects of the disease known as "breakbone fever," according to a large trial. Read more...         

TOPICS:

Compounding Pharmacy Oversight Changes Signed

July 11, 2014 2:38 pm | News | Comments

Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies. Read more...

TOPICS:

ACS to Publish Chemistry-Focused ID Research

July 11, 2014 11:28 am | News | Comments

The ACS announced Courtney Aldrich, Ph.D., will be the editor-in-chief of the brand-new, web-only journal ACS Infectious Diseases, which will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research, with the first issue slated for publication in January 2015. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading